Atlas Trials

Combination Therapy With Infliximab and Tofacitinib for Acute Severe Ulcerative Colitis - CINTO Trial

Clinical trial NCT07297069 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07297069
Sponsor
Asian Institute of Gastroenterology, India
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Severe Ulcerative Colitis
Start date
2026-01-01
Primary completion
2027-05-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.